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Sickle cell disease (SCD) is a hemolytic anemia quite prevalent in Oman, with the most recent epidemiological data suggesting a sickle cell gene 
carrier rate of about 6% and SCD prevalence of 0.2%.1,2 
The disease is characterized by a change in the shape 
of red cells to the classical sickled shape leading to a 
process of vessel occlusion involving the smallt and met
diumtsized vessels in almost all parts of the body. The 
process of vasotocclusion is made worse by episodes of 
infections, dehydration or deoxygenation.3 
It is also known that patients with SCD are at an 
increased risk of thrombosis and this process is considt
ered to contribute to several clinical features of the dist
ease including leg ulcers, priapism, avascular necrosis of 
bone, pulmonary hypertension, acute chest syndrome, 
stroke, and apparently any random infarctive lesions 
that can occur anywhere in the body. The cochlea, the 
organ of hearing, is not immune from this process and 
audiometric assessment is a sensitive indicator of any 
sensorineural (perceptive) hearing loss resulting from 
any occlusive vascular involvement.4 
The prevalence of involvement of the ears in SCD pat
tients is variable but it is reported to occur between 11% 
to 41% in black patients with this disease and can lead 
to sensorineural hearing loss (SNHL).5,6 The pattern of 
involvement is also variable and it can be either unilatt
eral, bilateral, temporary or permanent.7,8 We report on 
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a sickle cell disease (sCD) patient with vaso-occlusive crisis (VoC) developed sudden senserinural hear-
ing loss (snhL), which responded well to a rapid course of corticosteroids along with exchange trans-
fusions. the otolaryngologist should be aware of the otologic manifestations of sCD such as snhL. a 
good response to steroids, which averted a permanent hearing loss, warrants further studies to define the 
augmentive benefits of such therapy along with exchange transfusions in patients with sCD in VoC who 
develop sudden snhL.
a young female with a complicated history of SCD who 
presented with a sudden onset of sensorineural hearing 
loss (SNHL) that completely resolved following antet
cedent medical therapy. We wish to highlight here the 
need for appropriate and rapid audiometric evaluation 
and followtup treatment so that a reversible and treatt
able cause for rapid hearing loss in patients with SCD 
with VOC such as ours can be quickly achieved. 
CASE
A 26tyeartold Omani female with SCD (Hb S/S genot
type) was admitted in January 2010 with acute painful 
crisis involving the chest, legs and back. Her medical 
history was significant and included a stroke in childt
hood with complete neurological recovery, protein C 
deficiency, acute chest syndrome, and iron overload 
due to repeated blood transfusions/exchange. She was 
taking hydroxyurea, desferoxamine, penicillin V, folic 
acid, cotcodamol, aspirin and enoxaparin. On admist
sion, she had stable vital signs with pallor and icterus. 
She was treated with hydration, pain management with 
morphine infusion and nontsteroidal antitinflammat
tory drugs. Two days after admission, the patient awoke 
with acute complete hearing loss in the left ear. There 
was no history of imbalance or vertigo and she was 
otherwise well, apart from her ongoing painful crisis. 
Her hearing had previously been considered normal. 
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Furthermore, clinical examination found no neurologit
cal deficit. Investigations showed hemoglobin 7.5 g/dL, 
white blood cells 12.1×109/L, platelets 344×109/L, 
reticulocytes 538×109/L (25%), hemoglobin S 70.8%, 
hemoglobin F 1.0%, hemoglobin A 24.6% (transfused 
blood), hemoglobin A2 3.4%, lactate dehydrogenase 
640 μ/L (normal range, 135t214), haptoglobin <0.06 
g/L, total bilirubin 88 μmol/L, with otherwise normal 
renal and liver functions. 
She was evaluated in the ENT department, and aut
diometry, middle ear compliance, acoustic reflex, and 
tone decay were ordered. Audiometry studies showed 
a profound hearing loss in the left ear and mild hearing 
loss in the right (Figure 1 top). Radiological evaluation 
showed a normal chest xtray, ultrasound of the abdot
men showed gallstones, magnetic resonance imaging 
with angiogram of the brain did not reveal any new neut
rological lesions except for a large frontal cystic encepht
alomalacia due to an old infarction. She had extensive 
investigations to look for an underlying pathology, int
cluding autoimmune work such as antinuclear antibodt
ies, autoantibody screen and antineutrophilic antibodt
ies and they were all negative. Polymerase chain react
tion (PCR) for CMV, hepatitis B, C and HIV were all 
negative, and rapid plasma reagin as well as Treponema 
pallidum hemagglutination were also negative. She was 
treated with exchange transfusions and started on oral 
steroids (prednisone 60 mg daily for a week), which was 
gradually reduced over two weeks. Additionally she ret
ceived beta histadine 16 mg three times daily, as well 
as exchange transfusions. Audiometry was done every 
three days and the patient discharged with normal heart
ing in both ears in 2 weeks (Figure 1 bottom). 
DISCUSSION
Normal erythrocytes are compressible, disctshaped 
cells that flow easily through the smallest blood vest
sels, navigating blood vessels that are 1/3 of their diamt
eter; these cells live about 120 days. In stark contrast, 
in SCD patients the abnormally sickletshaped red cells 
are rigid, and get stuck in small blood vessels, leading 
to the most frequent manifestations of this disease, 
namely vasocclusion. Moreover these red cells live for 
only 20 or fewer days, perpetuating the vicious cycle of 
increased red cell production followed by increased red 
cell destruction. The sickle cells interrupt blood flow 
by blocking small blood vessels especially in the capilt
larytvenous bed, where the partial pressure of oxygen 
is reduced, promoting and accelerating the sickle shape 
change. This morphological change, and its associated 
physiological change, drastically reduces the ability of 
red blood cell to navigate and deliver oxygen throught
out the body.9 
SNHL is a multitfactorial process with idiopathic 
sudden SNHL being the most common diagnosis. The 
cochlea is highly sensitive to disruption of blood flow, 
and occlusion of labyrinthine vessels were shown in an 
animal model by Perlman to induce irreversible hearing 
loss.10 Ischemia of the stria vascularis, increased blood 
viscosity by crystallization of red blood cells, with det
velopment of stasis, ischemia or hypoxia appears to be 
the outstanding pathophysiological phenomenon durt
ing crisis.11 Given its size, this tiny organ receives a dist
proportionate percentage of the body’s blood and the 
extensive cochlear vascular anatomy, the high metabolic 
activity required to maintain both ionic and electrical 
characteristics of endolymph, and the highly dependent 
nature of evoked responses from the inner ear on brief 
episodes of anoxia, suggest that a secure and extensive 
cochlea blood flow is critical.12 
Our patient presented with crisis due to SCD and 
Figure 1. Pure tone audiogram before (top) and after (bottom) treatment.
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developed sudden hearing loss in all the frequencies 
of more than 30 dB of the left ear, strengthening the 
evidence that this process was related to SCD and she 
was treated with rapid exchange transfusions and stet
roids. Interestingly, she presented with a number of 
confounding factors. She had a history of stroke, and 
although she had a normal hearing following the stroke, 
with no neurological deficit, it is conceivable that she 
was at a high risk of developing a vascular CNS event. 
Furthermore, she was intermittently on desferoxamine, 
an agent that is linked with auditory complications, alt
though usually this is only thought to occur at a lower 
ferritin level, and her current ferritin level was 2930 
ng/mL (reference range, 20t300 ng/mL). This patient 
also had a complicated clinical course and presented 
with painful crisis, had a low hemoglobin level, with a 
very high reticulocyte count (known for their adhesive 
properties) and high hemoglobin S level, all features 
supportive of aggravating a vasotocclusive process due 
to SCD. However, we had simultaneously investigatt
ed her extensively to exclude other causes of sudden 
SNHL such as infection with negative viral studies, or 
no serological evidence of syphilis, and no evidence of 
autoimmune disease as documented by negative autot
immune markers. Furthermore this patient responded 
extremely well to steroids with rapid resolution of her 
symptoms and the hence the rare possibility of an aut
toimmune process cannot be completely ruled out. A 
rapid short course of steroid can be recommended in 
such cases, unless there is an absolute contraindication 
to their use, as the consequences of permanent hearing 
loss are profound. 
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